Prince Pharmaceutical Co., Ltd.
TWO: 6935.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Da Li
- Employees
- 210
- Headquarters
- Yunlin County, Taiwan
- IPO year
- 2023
- Market cap
- NT$1.2B
- Website
- https://www.prince-pharm.com.tw
Loading 6935…
Loading profile data…Frequently asked questions about 6935
What does Prince Pharmaceutical Co., Ltd. (6935.TWO) do?
Prince Pharmaceutical Co., Ltd. manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally. The company also offers health food and medicines; vitamin c tablets, vitamin b complex tablets, natto and rhodiola extract capsules, probiotic sachets, and plant extract capsules; and API produ...
Where does 6935.TWO trade?
Prince Pharmaceutical Co., Ltd. (6935.TWO) trades on the Taipei Exchange.
What sector is 6935.TWO in?
Prince Pharmaceutical Co., Ltd. (6935.TWO) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Prince Pharmaceutical Co., Ltd.?
Da Li is the chief executive officer of Prince Pharmaceutical Co., Ltd. (6935.TWO).
Where is Prince Pharmaceutical Co., Ltd. headquartered?
Prince Pharmaceutical Co., Ltd. is headquartered in Taiwan.
Does 6935.TWO pay a dividend?
Yes — Prince Pharmaceutical Co., Ltd. (6935.TWO) paid a trailing twelve-month dividend of TWD 0.25 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 6935.TWO go public?
Prince Pharmaceutical Co., Ltd. (6935.TWO) completed its initial public offering in 2023.